Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. - Khanani AM; Danzig CJ; Heier JS; Jaffe GJ; Kaiser PK; Lally DR; Patel SS; Vajzovic L; Weng CY; Patel H; Clark J; Desai D; et al. (Ophthalmology, 2026)